Insider · CIK 0001585018

Hesslein Robert W.

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001585018

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-03	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, CLO and Secretary	AAward	+757 sh	—	—	8,002
2025-03-03	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	EVP, CLO and Secretary	AAward	+1,529 sh	—	—	1,529
2024-10-01	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, CLO and Secretary	AAward	+7,245 sh	—	—	7,245
2023-03-20	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−4,410 sh	$7.76	−$34.2K	102,200
2023-02-17	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−3,297 sh	$7.45	−$24.6K	106,610
2023-02-13	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−2,868 sh	$7.67	−$22K	109,907
2023-01-17	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−1,396 sh	$9.57	−$13.4K	113,567
2023-01-17	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−792 sh	$10.34	−$8,189.28	112,775
2022-04-04	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−2,786 sh	$8.25	−$23K	114,963
2022-03-21	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−4,897 sh	$8.29	−$40.6K	117,807
2022-03-21	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−58 sh	$8.68	−$503.44	117,749
2022-02-17	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−4,100 sh	$3.55	−$14.6K	122,704
2022-02-11	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−3,252 sh	$3.36	−$10.9K	126,804
2022-01-13	VYGRVoyager Therapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+20K sh	—	—	130,056
2022-01-13	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+120K sh	—	—	120,000
2021-04-05	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	+3,292 sh	$4.95	+$16.3K	110,056
2021-03-19	VYGRVoyager Therapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+30K sh	—	—	113,348
2021-02-16	VYGRVoyager Therapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+34K sh	—	—	83,348
2021-02-16	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+68K sh	—	—	68,000
2021-02-11	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−3,186 sh	$7.55	−$24.1K	49,348
2020-04-03	VYGRVoyager Therapeutics, Inc.S Sale	Senior VP & General Counsel	SSale	−3,091 sh	$8.51	−$26.3K	52,534
2020-02-10	VYGRVoyager Therapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+27.5K sh	—	—	55,625
2020-02-10	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+55K sh	—	—	55,000
2019-04-01	VYGRVoyager Therapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+28.1K sh	—	—	28,125
2019-04-01	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+169K sh	—	—	168,750
2018-07-31	Foundation Medicine, Inc.U Disposition from Tender	SVP and General Counsel	UDisposition from Tender	−76.5K sh	$137.00	−$10.5M	28,709
2018-07-31	Foundation Medicine, Inc.J Other	SVP and General Counsel	JOther	−28.7K sh	$137.00	−$3.93M	0
2018-07-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−2,520 sh	$136.66	−$344K	105,203
2018-04-02	Foundation Medicine, Inc.M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+2,344 sh	$7.12	+$16.7K	109,308
2018-04-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,585 sh	$74.88	−$119K	107,723
2018-04-02	Foundation Medicine, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−2,344 sh	—	—	0
2018-04-01	Foundation Medicine, Inc.A Award	SVP and General Counsel	AAward	+8,621 sh	$78.75	+$679K	106,964
2018-01-16	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−18K sh	$64.30	−$1.16M	98,343
2018-01-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,392 sh	$64.00	−$89.1K	116,836
2018-01-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−472 sh	$64.00	−$30.2K	116,364
2017-10-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,502 sh	$38.80	−$58.3K	118,891
2017-10-02	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−663 sh	$38.80	−$25.7K	118,228
2017-07-06	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−3,372 sh	$38.84	−$131K	122,091
2017-07-06	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,246 sh	$38.84	−$48.4K	120,845
2017-07-06	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−452 sh	$38.84	−$17.6K	120,393
2017-06-08	Foundation Medicine, Inc.M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+4,689 sh	$4.16	+$19.5K	123,119
2017-06-08	Foundation Medicine, Inc.M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+2,344 sh	$7.12	+$16.7K	125,463
2017-06-08	Foundation Medicine, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−4,689 sh	—	—	0
2017-06-08	Foundation Medicine, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−2,344 sh	—	—	2,344
2017-05-12	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,009 sh	$33.87	−$34.2K	118,430
2017-05-01	Foundation Medicine, Inc.A Award	SVP and General Counsel	AAward	+16.4K sh	$35.80	+$586K	119,439
2017-04-03	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,233 sh	$31.96	−$39.4K	103,072
2017-03-16	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−6,231 sh	$31.67	−$197K	104,305
2017-01-04	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−1,426 sh	$18.49	−$26.4K	110,536
2017-01-03	Foundation Medicine, Inc.S Sale	SVP and General Counsel	SSale	−3,256 sh	$17.41	−$56.7K	111,962

Recent filings

Accepted (ET)
Mar 54
Hesslein Robert W.0001735276-25-000035
SEC(opens sec.gov)
Oct 34
Hesslein Robert W.0001735276-24-000096
SEC(opens sec.gov)
Mar 224
Hesslein Robert W.0001104659-23-035638
SEC(opens sec.gov)
Feb 224
Hesslein Robert W.0001104659-23-024424
SEC(opens sec.gov)
Feb 154
Hesslein Robert W.0001104659-23-022429
SEC(opens sec.gov)
Jan 194
Hesslein Robert W.0001104659-23-005053
SEC(opens sec.gov)
Apr 64
Hesslein Robert W.0001104659-22-043244
SEC(opens sec.gov)
Mar 234
Hesslein Robert W.0001104659-22-037153
SEC(opens sec.gov)
Feb 224
Hesslein Robert W.0001104659-22-025672
SEC(opens sec.gov)
Feb 154
Hesslein Robert W.0001104659-22-023834
SEC(opens sec.gov)
Jan 184
Hesslein Robert W.0001104659-22-005022
SEC(opens sec.gov)
Apr 74
Hesslein Robert W.0001104659-21-047689
SEC(opens sec.gov)
Mar 234
Hesslein Robert W.0001104659-21-040307
SEC(opens sec.gov)
Feb 184
Hesslein Robert W.0001104659-21-025273
SEC(opens sec.gov)
Feb 164
Hesslein Robert W.0001104659-21-023939
SEC(opens sec.gov)

Companies

Address

C/O FOUNDATION MEDICINE, INC. ONE KENDALL SQUARE, SUITE B3501

CAMBRIDGE, MA, 02139